The United Kingdom is experiencing a burgeoning interest in altered states of consciousness, particularly N,N-Dimethyltryptamine and Cannabigerol . Researchers are progressively examining the potential of these compounds for medical purposes, leading a nuanced dialogue around their ethical status an